Dr. Cagle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
# MS205
Houston, TX 77030Phone+1 713-394-6450Fax+1 713-441-3886
Education & Training
Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 1981 - 1985
University of Tennessee Health Science Center College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1983 - 2024
TN State Medical License 1981 - 1998- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 111 citationsUpdated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of Ame...Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley
The Journal of Molecular Diagnostics. 2018-03-01 - 93 citationsAtypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the LungMasuko Mori, Sudha K. Rao, Helmut Popper, Philip T. Cagle, Armando E. Fraire
Modern Pathology. 2001-02-01 - 108 citationsMolecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, Int...Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Chitale, Sanja Dacic
The Journal of Molecular Diagnostics. 2013-07-01
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018
Press Mentions
Lung Guideline Goals: More Tests, TreatmentMarch 15th, 2018
Frontiers in Thoracic PathologyJuly 3rd, 2017- Educational Endeavors: Contributions from Leaders in Our CommunityJuly 20th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
